[1]
2026. Characterization of ALDH1A1 Positive Cancer Stem Cells in Glioblastoma Multiforme and Their Response to Temozolomide. Journal of Cancer Research Updates. 15, 3 (Sep. 2026), 328–337. DOI:https://doi.org/10.30683/1929-2279.2026.15.29.